Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study

Cancer Research

Volumn 61, Issue 19, 2001, Pages 7233-7239

  Whitman, S P ^a   Archer, K J ^a   Feng, L ^a   Baldus, C ^a   Becknell, B ^a   Carlson, B D ^a   Carroll, A J ^a   Mrozek K ^a   Vardiman, J W ^a   George, S L ^a   Kolitz, J E ^a   Larson, R A ^a   Bloomfield, C D ^a   Caligiuri, M A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLELE; ARTICLE; CANCER SURVIVAL; CYTOGENETICS; FEMALE; GENE DUPLICATION; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ALLELES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DISEASE-FREE SURVIVAL; FEMALE; FMS-LIKE TYROSINE KINASE 3; GENE DUPLICATION; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; TANDEM REPEAT SEQUENCES; TREATMENT OUTCOME;

EID: 0035476264     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The expression of FMS, KIT and FLT3 in hematopoietic malignancies
2. FLT3: Receptor and ligand. Biology and potential clinical application
3. Cell signaling by receptor tyrosine kinases
4. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells
5. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: Regulation of Bcl-2 and Bax
6. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia
7. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines
8. Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene
9. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia
10. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product
11. Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells
12. Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation
13. Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines
14. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways
15. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia
16. Parallel phase I trials of multi-drug resistance (MDR) modulation with PSC-833 (PSC) in untreated patients (pts) with acute myeloid leukemia <60 years old: Preliminary results of CALGB 9621
17. Cytogenetic risk-adapted intensification followed by immunotherapy with recombinant interleukin-2 (rIL-2) in patients with acute myeloid leukemia in first complete remission (CR): Preliminary results of CALGB 9621
18. A comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A Cancer and Leukemia Group B Study
19. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group
20. Incidence and prognostic significance of internal tandem duplications of the FLT3 gene in AML with normal cytogenetics: Analysis of 84 patients treated within a multicenter trial AML HD93
21. Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia
22. Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia
23. Human acute myeloid leukemia cells with internal tandem duplication in the Flt3 gene show reduced proliferative ability in stroma supported long-term cultures
24. Multiple signaling pathways mediate leukemogenic activity of internal tandem duplication mutations of FLT3 in AML
25. A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation
26. Full activation of the platelet-derived growth factor β-receptor kinase involves multiple events
27. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
28. Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells